Andrea Lynn Maria Silber MD
Associate Clinical Professor of Medicine (Medical Oncology)
breast cancer, particularly breast cancer in younger women, and the differences in breast cancer in diverse populations.
- Internal Medicine, Board Certified
Patient Care Locations
|Gastrointestinal Tumors, Metastatic Breast Cancer, Breast - Female, Colon, Esophagus, Rectum, and Stomach||Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients with Advanced Breast and Gastrointestinal Tumors|
|Breast Cancer and Breast - Female||NSABP B-47 A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer|
|Cancer, Breast - Female, and Breast - Male||Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer (S1207)|